Figures & data
Figure 2 Randomised clinical trials at each stage of disease progression for COVID-19.
![Figure 2 Randomised clinical trials at each stage of disease progression for COVID-19.](/cms/asset/500e5db2-929c-4e6b-8885-34a9a91db6e6/didr_a_288399_f0002_c.jpg)
Figure 3 Distribution of number of arms for (A) all and (B) (hydroxy)chloroquine randomized clinical trials for COVID-19, arranged by clinical setting.
![Figure 3 Distribution of number of arms for (A) all and (B) (hydroxy)chloroquine randomized clinical trials for COVID-19, arranged by clinical setting.](/cms/asset/77cc0daf-18c9-43ca-8440-a41fb2f17df3/didr_a_288399_f0003_c.jpg)
Figure 4 Distribution of COVID-19 randomized clinical trials and enrollment target for key drugs, arranged by clinical setting.
![Figure 4 Distribution of COVID-19 randomized clinical trials and enrollment target for key drugs, arranged by clinical setting.](/cms/asset/fb44ceb3-a036-4ee5-9f66-218383dbeb2c/didr_a_288399_f0004_c.jpg)
Figure 5 Treatment network for (A) pre-exposure and (B) post-exposure randomized clinical trials for COVID-19.
![Figure 5 Treatment network for (A) pre-exposure and (B) post-exposure randomized clinical trials for COVID-19.](/cms/asset/80db36fc-47ed-4856-be26-31518021266f/didr_a_288399_f0005_b.jpg)
Figure 6 Treatment network for (A) outpatient and (B) hospitalized or intensive care unit randomized clinical trials for COVID-19.
![Figure 6 Treatment network for (A) outpatient and (B) hospitalized or intensive care unit randomized clinical trials for COVID-19.](/cms/asset/dcccf985-2bae-44c1-88c9-bd87286b2661/didr_a_288399_f0006_b.jpg)